NING ZHANG

Notable Representation(s):

• Advised client on licensing matter for joint development program between a U.S. pharmaceutical company and a Chinese pharmaceutical company.
  

• Represented more than ten foreign clients in their joint ventures or strategic alliance projects in China and other jurisdictions, including Hong Kong, Singapore, Cayman Islands, BVI and U.S., including Regal Beloite and East Pennsylvania Manufacturing
  

• Represented and participated in a number of transactions where the U.S. investors disposed their interests in Chinese entities
  

• Represented Shanghai Automobile Air Conditioning Factory (SAACF) in the acquisition of Dephi Automotive’s equity interest in a joint venture with SAACF
  

• Represented a major U.S. high tech company in strategic acquisitions of various companies or assets, involving deep learning, cloud technology, CDMA business, etc.
  

• Represented Google Capital in a proposed acquisition of an online education site in China
  

• Represented Hepalink, a Chinese company listed on Shenzhen Stock Exchange, in its acquisition of its competitor in the U.S. and its investment in a medical fund in the U.S.
  

• Represented ICBC in its acquisition of a Taiwan commercial bank
  

• Represented owners of a Chinese hospital restructure its business in a sale to a British strategic investor
  

• Represented certain medical fund in China to invest in various U.S. companies in Pre-IPO rounds
  

• Represented a well-known U.S. pharmaceutical company in its investment in Chinese pharmaceutical companies through its fund in Asia
  

• Represented Chinese investors in Series F investment in AirBnB and Uber
  

• Represented a number of start-ups in various financing rounds.

Area of Expertise

• Commercial Contracts

• Corporate General Counsel

• Mergers and Acquisitions

Browse Further Profiles